In both of these cases, the same genomic analysis was performed on a matched tumor, showing very good concordance between the tumor and the plasma profiles, including the detection of Human Epidermal Growth Factor Receptor 2 (ERBB2) amplification in the samples from patient 15 (Figure 1B). Here, ERBB2 is linked to neoplasm.